Fig. 5.

Plasma tramiprosate exposure versus dose relationships after an oral ALZ-801 tablet and capsule in healthy humans show strong dose-exposure proportionality under all conditions (Studies 2 and 3 in Table 1). AUC area under the concentration–time curve, AUC ₁₂ AUC from time zero to 12 h